Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myr (MYRG) Accumulated Expenses (2016 - 2025)

Myr (MYRG) has disclosed Accumulated Expenses for 16 consecutive years, with $28.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Accumulated Expenses rose 10.11% to $28.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $28.5 million, a 10.11% increase, with the full-year FY2025 number at $28.5 million, up 10.11% from a year prior.
  • Accumulated Expenses was $28.5 million for Q4 2025 at Myr, up from $26.8 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $28.8 million in Q4 2022 to a low of $23.5 million in Q2 2022.
  • A 5-year average of $25.8 million and a median of $25.5 million in 2021 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: grew 28.32% in 2021, then fell 11.0% in 2024.
  • Myr's Accumulated Expenses stood at $24.2 million in 2021, then rose by 18.6% to $28.8 million in 2022, then fell by 1.68% to $28.3 million in 2023, then dropped by 8.44% to $25.9 million in 2024, then rose by 10.11% to $28.5 million in 2025.
  • Per Business Quant, the three most recent readings for MYRG's Accumulated Expenses are $28.5 million (Q4 2025), $26.8 million (Q3 2025), and $26.8 million (Q2 2025).